Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

CUSIP: 185063104

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
76,991,404
Total 13F shares
12,782,054
Share change
-5,761,910
Total reported value
$13,666,526
Put/Call ratio
0%
Price per share
$1.07
Number of holders
66
Value change
-$30,790,524
Number of buys
29
Number of sells
56

Quarterly Holders Quick Answers

What is CUSIP 185063104?
CUSIP 185063104 identifies CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q4 2018

As of 31 Dec 2018, Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,782,054 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., SPHERA FUNDS MANAGEMENT LTD., UBS Group AG, NORTHPOINTE CAPITAL LLC, Vanguard Group Inc, MILLENNIUM MANAGEMENT LLC, DEUTSCHE BANK AG\, RENAISSANCE TECHNOLOGIES LLC, and STATE STREET CORP. This page lists 66 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.